Overview
The fund generally invests in stocks contained in the SPI. The relative weightings of the companies is tilted toward their expected contribution to climate change.
The investment objective is to replicate the price and return performance of the SPI net of fees maintaining a rule-based orientation mitigating the effects of climate change risk.
The aim is to limit exposure to greenhouse gas emissions and considering how companies contribute to the transition to a low carbon economy.
The carbon profile of the portfolio is aligned with a net zero (1.5 degree) glide path targeting net-zero by 2050.
The typical ex-ante tracking error is expected to be approximately 0.5% p.a. The maximum ex-ante tracking error target value is less than 1%.
No investments in securities on the recommendation list for the exclusion of SVVK-ASIR (www.svvk-asir.ch) and the UBS SA国际传谋 Sustainability Exclusion Policy.
Securities lending is not allowed.
Benefits
Easy access to the Swiss stock market with a glide path targeting net-zero by 2050.
Optimized risk/return profile thanks to a broad diversification across a range of sectors.
Provides access to the performance of the index with a single transaction.
The fund is transparent and cost-effective and is liquid under normal market conditions.
You do not pay any federal stamp duty.
Risks
Features
| Product category |
Equity Switzerland |
| Product domicile |
Switzerland
|
| Portfolio management |
UBS SA国际传谋 Switzerland AG, Zurich
|
| Fund management |
UBS Fund Management (Switzerland) AG
|
| Custodian bank |
UBS Switzerland AG, Zurich
|
| Day of inception |
June 8, 2023
|
| Currency of account |
CHF
|
| Close of financial year |
September 30
|
| SFDR Classification |
n.a.
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.01% p.a.
|
| Flat fee |
0.00% p.a.
|
| Management fee |
0.00% p.a.
|
| Total expense ratio (TER) |
0.01% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
SPI®
|
| Cut-Off Time |
15:00h(CET)
|
| Securities no. |
126624599
|
| ISIN |
CH1266245997
|
| Bloomberg Ticker |
UBESZIX SW
|
Performance and Prices
Percentage growth
as of April 23, 2026| CHF(%) | EUR(%) | USD(%) | |
| YTD | 3.13 | 4.56 | 4.26 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 22.51 | 30.02 | 42.33 |
| 3Y | |||
| 5Y | |||
| ø p.a.5Y | 10.68 | 14.03 | 19.30 |
Current data
| Net asset value | 23.04.2026 | CHF 1,232.76 |
| High - last 12 months | 27.02.2026 | CHF 1,268.26 |
| Low - last 12 months | 24.04.2025 | CHF 1,081.64 |
| Assets of the unit class in mn | 23.04.2026 | CHF 583.96 |
| Total product assets in mn | 23.04.2026 | CHF 727.02 |
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 31.03.2026 | 11.72% | n.a. |
| Sharpe Ratio | 31.03.2026 | 0.59 | n.a. |
| Risk Free Rate | 31.03.2026 | 0.46% | 0.40% |
Structures
By the 10 largest equity positions (in %, as of March 31, 2026)
|
|
|
| Novartis AG | 14.23 |
| Roche Holding AG | 13.55 |
| Nestle SA | 11.52 |
| ABB Ltd | 6.23 |
| UBS Group AG | 5.87 |
| Zurich Insurance Group AG | 5.79 |
| Cie Financiere Richemont SA | 4.40 |
| Swiss Re AG | 3.01 |
| Lonza Group AG | 2.33 |
| Alcon AG | 2.31 |
Fees
Distributions
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|
| Prospectus |
|
|
| Key Information Document |
|
|
| Past performance |
|
|
| Previous performance scenario |
|
|
|
Document type
|
Document Language
|
|
| Annual report |
|
|
| Semi-annual report |
|
|
| AMAS Periodic Report |
|